Literature DB >> 11083550

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.

C Decristoforo, W Cholewinski, E Donnemiller, G Riccabona, R Moncayo, S J Mather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083550     DOI： 10.1007/s002590000354

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  4 in total

1.  Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Authors:  C Decristoforo; S J Mather
Journal:  Eur J Nucl Med       Date:  1999-08

2.  99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.

Authors:  C Decristoforo; L Melendez-Alafort; J K Sosabowski; S J Mather
Journal:  J Nucl Med       Date:  2000-06       Impact factor: 10.057

3.  Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.

Authors:  M Bangard; M Béhé; S Guhlke; R Otte; H Bender; H R Maecke; H J Biersack
Journal:  Eur J Nucl Med       Date:  2000-06

4.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09
  4 in total
  2 in total

1.  In vitro structure-activity relationship of Re-cyclized octreotide analogues.

Authors:  Shorouk F Dannoon; Heather M Bigott-Hennkens; Lixin Ma; Fabio Gallazzi; Michael R Lewis; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2010-07       Impact factor: 2.408

2.  Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.

Authors:  Saeed Mozaffari; Mostafa Erfani; Davood Beiki; Fariba Johari Daha; Farzad Kobarfard; Saeed Balalaie; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.